Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1996 1
2003 2
2004 1
2014 1
2015 1
2017 1
2021 1
2022 2
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer.
Rossokha Z, Fishchuk L, Lobanova O, Vershyhora V, Medvedieva N, Cheshuk V, Vereshchako R, Podolska S, Gorovenko N. Rossokha Z, et al. Among authors: cheshuk v. J Cancer Res Clin Oncol. 2023 Oct;149(13):11919-11927. doi: 10.1007/s00432-023-05034-0. Epub 2023 Jul 7. J Cancer Res Clin Oncol. 2023. PMID: 37420018
Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.
Samusieva A, Serga S, Klymenko S, Rybchenko L, Klimuk B, Zakhartseva L, Gorovenko N, Lobanova O, Rossokha Z, Fishchuk L, Levkovich N, Medvedieva N, Popova O, Cheshuk V, Inomistova M, Khranovska N, Skachkova O, Michailovich Y, Ponomarova O, Kozeretska I. Samusieva A, et al. Among authors: cheshuk v. Breast Cancer Res Treat. 2022 Oct;195(3):453-459. doi: 10.1007/s10549-022-06692-3. Epub 2022 Aug 5. Breast Cancer Res Treat. 2022. PMID: 35930098
CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT.
Fishchuk L, Lobanova O, Rossokha Z, Cheshuk V, Vereshchako R, Vagyn Y, Kashuba V, Vershyhora V, Popova O, Levkovich N, Zemlianska O, Ievseienkova O, Podolska S, Gorovenko N. Fishchuk L, et al. Among authors: cheshuk v. Exp Oncol. 2023 Oct 11;45(2):161-169. doi: 10.15407/exp-oncology.2023.02.161. Exp Oncol. 2023. PMID: 37824776
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine.
Gorodetska I, Serga S, Levkovich N, Lahuta T, Ostapchenko L, Demydov S, Anikusko N, Cheshuk V, Smolanka I, Sklyar S, Polenkov S, Boichenko O, Kozeretska I. Gorodetska I, et al. Among authors: cheshuk v. Hered Cancer Clin Pract. 2015 Oct 13;13:19. doi: 10.1186/s13053-015-0040-3. eCollection 2015. Hered Cancer Clin Pract. 2015. PMID: 26468334 Free PMC article.
15 results